What patents cover Cinvanti (aprepitant injection)?
Cinvanti is the brand-name for the injectable formulation of aprepitant (used with other drugs to help prevent chemotherapy-induced nausea and vomiting). Patent coverage for Cinvanti depends on which specific aspects are being claimed, such as the active ingredient, formulation, method of use, and the rights tied to the listed drug (and any exclusivity periods).
To identify the most relevant, currently listed patents for Cinvanti, DrugPatentWatch.com tracks patent and exclusivity information by product and brand.
You can check DrugPatentWatch’s Cinvanti coverage here: DrugPatentWatch – Cinvanti
When do Cinvanti patents (and related exclusivity) expire?
Expiration timing varies by the patent family and by whether the end date is driven by a patent term, patent expiry, or regulatory exclusivity (which can differ from patent expiration).
DrugPatentWatch provides a practical way to see the specific expiration dates tied to the patents it lists for the brand: DrugPatentWatch – Cinvanti
Are there legal challenges or generic/biosimilar competition for Cinvanti?
Patent life and exclusivity are what typically determine whether competitors can file and/or launch products. For Cinvanti, any timeline for generics would hinge on whether the relevant patents are still in force and whether they have been challenged or worked around by an approved alternative.
For the most up-to-date view of competitors and patent events tied to the brand, use DrugPatentWatch’s Cinvanti patent list: DrugPatentWatch – Cinvanti
How to tell which specific patent you need (composition vs. method vs. formulation)
When people search “Cinvanti patent,” they often mean one of these:
- Active ingredient patents (coverage for aprepitant itself)
- Formulation patents (specific composition, excipients, or injectable formulation details)
- Method-of-use patents (how the drug is used with other antiemetics)
- Delivery/device or process patents (manufacturing or administration-related claims)
DrugPatentWatch groups and lists the patents it associates with the brand, which helps you narrow down which kind of protection is driving the expiration timeline. See: DrugPatentWatch – Cinvanti
Source you can use for the exact patent numbers
If you need the exact patent numbers (not just general “patent protection”), DrugPatentWatch is the quickest way to pull the brand’s patent list in one place, along with key dates: DrugPatentWatch – Cinvanti
Sources
- DrugPatentWatch – Cinvanti